v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (6,780) $ (6,302)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 130 102
Stock-based compensation 312 350
Non-cash lease expense 34 61
Changes in operating assets and liabilities:    
R&D tax credit incentive receivable (43) 78
Prepaid expenses and other assets (141) 168
Accounts payable 433 175
Accrued compensation expenses (16) 7
Accrued expenses (125) 198
Net cash used in operating activities (6,196) (5,163)
Cash flows from investing activities:    
Purchases of property and equipment (3) (5)
Net cash used in investing activities (3) (5)
Cash flows from financing activities:    
Issuance of common stock in connection with 2025 Private Sales Transactions 5,650
Issuance of common stock in connection with 2026 Registered Direct Offering, net of issuance costs 2,174
Issuance of common stock in connection with 2026 Private Placement, net of issuance costs 1,997  
Payments on insurance premium loan (107) (142)
Net issuance costs in connection with the Sales Agreement (28)
Net cash provided by (used in) financing activities 9,714 (170)
Effect of exchange rate changes on cash and cash equivalents 2 (6)
Net increase (decrease) in cash, cash equivalents and restricted cash 3,517 (5,344)
Cash, cash equivalents and restricted cash balance at beginning of period 17,570 19,690
Cash, cash equivalents and restricted cash balance at end of period 21,087 14,346
Cash paid during the period for:    
Income taxes 2
Non-cash investing and financing activities:    
Purchases of property and equipment in accounts payable and accrued expenses $ 12